Page last updated: 2024-10-30

mesalamine and Granulomatous Disease, Chronic

mesalamine has been researched along with Granulomatous Disease, Chronic in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delgado, J1
Delgado, B1
Sztarkier, I1
Cagnano, E1
Sperber, AD1
Fich, A1

Other Studies

1 other study available for mesalamine and Granulomatous Disease, Chronic

ArticleYear
Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.
    The Israel Medical Association journal : IMAJ, 2003, Volume: 5, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Granulomatous Disease, Chronic; Huma

2003